These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 29622645)

  • 1. LRRK2 kinase in Parkinson's disease.
    Alessi DR; Sammler E
    Science; 2018 Apr; 360(6384):36-37. PubMed ID: 29622645
    [No Abstract]   [Full Text] [Related]  

  • 2. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
    Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
    Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of phospho-specific Rab protein antibodies to monitor
    Lis P; Burel S; Steger M; Mann M; Brown F; Diez F; Tonelli F; Holton JL; Ho PW; Ho SL; Chou MY; Polinski NK; Martinez TN; Davies P; Alessi DR
    Biochem J; 2018 Jan; 475(1):1-22. PubMed ID: 29127256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2 and Rab GTPases.
    Pfeffer SR
    Biochem Soc Trans; 2018 Dec; 46(6):1707-1712. PubMed ID: 30467121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the cellular consequences of LRRK2-mediated Rab protein phosphorylation.
    Fasiczka R; Naaldijk Y; Brahmia B; Hilfiker S
    Biochem Soc Trans; 2023 Apr; 51(2):587-595. PubMed ID: 36929701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration.
    Jeong GR; Jang EH; Bae JR; Jun S; Kang HC; Park CH; Shin JH; Yamamoto Y; Tanaka-Yamamoto K; Dawson VL; Dawson TM; Hur EM; Lee BD
    Mol Neurodegener; 2018 Feb; 13(1):8. PubMed ID: 29439717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular effects mediated by pathogenic LRRK2: homing in on Rab-mediated processes.
    Madero-Pérez J; Fdez E; Fernández B; Lara Ordóñez AJ; Blanca Ramírez M; Romo Lozano M; Rivero-Ríos P; Hilfiker S
    Biochem Soc Trans; 2017 Feb; 45(1):147-154. PubMed ID: 28202668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRRK2 phosphorylation of Rab GTPases in Parkinson's disease.
    Pfeffer SR
    FEBS Lett; 2023 Mar; 597(6):811-818. PubMed ID: 36114007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites.
    Nirujogi RS; Tonelli F; Taylor M; Lis P; Zimprich A; Sammler E; Alessi DR
    Biochem J; 2021 Jan; 478(2):299-326. PubMed ID: 33367571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Parkinson's disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4.
    Funk N; Munz M; Ott T; Brockmann K; Wenninger-Weinzierl A; Kühn R; Vogt-Weisenhorn D; Giesert F; Wurst W; Gasser T; Biskup S
    Sci Rep; 2019 Mar; 9(1):4515. PubMed ID: 30872638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic LRRK2 regulates ciliation probability upstream of tau tubulin kinase 2 via Rab10 and RILPL1 proteins.
    Sobu Y; Wawro PS; Dhekne HS; Yeshaw WM; Pfeffer SR
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33653948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinase activity of mutant LRRK2 manifests differently in hetero-dimeric vs. homo-dimeric complexes.
    Leandrou E; Markidi E; Memou A; Melachroinou K; Greggio E; Rideout HJ
    Biochem J; 2019 Feb; 476(3):559-579. PubMed ID: 30670570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular functions of LRRK2 implicate vesicular trafficking pathways in Parkinson's disease.
    Cookson MR
    Biochem Soc Trans; 2016 Dec; 44(6):1603-1610. PubMed ID: 27913668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Substrate Phosphorylation of LRRK2 in Tissues and Cultured Cells.
    Ito K; Xu L; Ito G; Tomita T
    Methods Mol Biol; 2021; 2322():53-61. PubMed ID: 34043192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease.
    Taylor M; Alessi DR
    Curr Opin Cell Biol; 2020 Apr; 63():102-113. PubMed ID: 32036294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A.
    Rivero-Ríos P; Romo-Lozano M; Madero-Pérez J; Thomas AP; Biosa A; Greggio E; Hilfiker S
    J Biol Chem; 2019 Mar; 294(13):4738-4758. PubMed ID: 30709905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cell Biology of LRRK2 in Parkinson's Disease.
    Usmani A; Shavarebi F; Hiniker A
    Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33526455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients.
    Atashrazm F; Hammond D; Perera G; Bolliger MF; Matar E; Halliday GM; Schüle B; Lewis SJG; Nichols RJ; Dzamko N
    Mov Disord; 2019 Mar; 34(3):406-415. PubMed ID: 30597610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seeing the bigger picture: First full-length human LRRK2 structures.
    Ullrich F
    Nat Struct Mol Biol; 2021 Jul; 28(7):546. PubMed ID: 34211164
    [No Abstract]   [Full Text] [Related]  

  • 20. Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation.
    Madero-Pérez J; Fdez E; Fernández B; Lara Ordóñez AJ; Blanca Ramírez M; Gómez-Suaga P; Waschbüsch D; Lobbestael E; Baekelandt V; Nairn AC; Ruiz-Martínez J; Aiastui A; López de Munain A; Lis P; Comptdaer T; Taymans JM; Chartier-Harlin MC; Beilina A; Gonnelli A; Cookson MR; Greggio E; Hilfiker S
    Mol Neurodegener; 2018 Jan; 13(1):3. PubMed ID: 29357897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.